PANACEABIO₹311.45-4.70%
52/100
0100 · strongest
good
Weights come from configuration, not from this page — each pillar links to the section below that explains it.
Income stmtHistory
Profitability
headline ratiosGrowth
compounded, from filed annual resultsSegment Results
₹ CrWorking Capital & Efficiency
days · ROCE %PANACEABIO financial summary
For Mar 2026, Panacea Biotec Ltd reported revenue of ₹413 crore, which grew 33.2% from the previous year. Net profit was -₹30 crore, on an operating margin of -4%. Earnings per share came in at -₹4.88. Annual results are available for 14 financial years, from Mar 2013 to Mar 2026.
| Revenue | ₹413 crore |
|---|---|
| Net profit | -₹30 crore |
| Operating margin | -4% |
| EPS | -₹4.88 |